Literature DB >> 8421999

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.

D A Duprez1, F R Bauwens, M L De Buyzere, T L De Backer, J M Kaufman, J Van Hoecke, A Vermeulen, D L Clement.   

Abstract

In a group of 36 untreated patients with mild-to-moderate essential hypertension (office systolic blood pressure [SBP] 160 +/- 3.4 mm Hg, office diastolic blood pressure [DBP], 102 +/- 1.5 mm Hg), 24-hour ambulatory blood pressure monitoring, and determination of left ventricular (LV) mass index according to the formula of Devereux were performed. After an overnight fast, blood samples were taken for the determination of serum aldosterone levels and plasma renin activity. Urinary catecholamine concentrations were assayed from 24-hour urine collections. Left ventricular mass index (143.7 +/- 8 g/m2) did not correlate significantly with either office SBP or office DBP. The correlation of LV mass index with mean 24-hour SBP (145 +/- 3 mm Hg) was statistically significant: r = 0.395, p = 0.026. However, the best correlation was obtained with mean 24-hour DBP (90 +/- 3 mm Hg) with r = 0.499 (p = 0.004). Urinary catecholamine levels did not correlate with LV mass index. In addition, LV mass index correlated significantly with plasma renin activity (r = 0.346, p = 0.050) and serum aldosterone levels (r = 0.559, p = 0.0009). There was a strongly significant correlation between LV mass index and serum aldosterone levels even after adjustment for mean 24-hour SBP (r = 0.496, p = 0.005) and DBP (r = 0.514, p = 0.004). These results demonstrate that ambulatory blood pressure determinations but not office blood pressure parameters correlate well with left ventricular hypertrophy in essential hypertension. Nonhemodynamic factors are important determinants of left ventricular mass as well.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421999     DOI: 10.1016/0002-9149(93)90240-d

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  Aldosterone: a forgotten mediator of the relationship between psychological stress and heart disease.

Authors:  Laura D Kubzansky; Gail K Adler
Journal:  Neurosci Biobehav Rev       Date:  2009-07-22       Impact factor: 8.989

2.  Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.

Authors:  Giuseppe Mulè; Emilio Nardi; Laura Guarino; Valentina Cacciatore; Giulio Geraci; Ilenia Calcaterra; Bruno Oddo; Francesco Vaccaro; Santina Cottone
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

3.  Expression and biochemical characteristics of two different aldosterone receptors in both healthy and dilated cardiomyopathy dog heart tissue.

Authors:  Alejandro R Reynoso Palomar; Moncerrat Rodriguez Bravo; Abel E Villa Mancera; Carlos J Mucha
Journal:  Vet Res Commun       Date:  2016-11-28       Impact factor: 2.459

Review 4.  Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.

Authors:  E Kaplinsky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 5.  Aldosterone and arterial hypertension.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Barbara Obermayer-Pietsch; Thomas R Pieber
Journal:  Nat Rev Endocrinol       Date:  2009-12-22       Impact factor: 43.330

Review 6.  Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.

Authors:  Adam Whaley-Connell; Megan S Johnson; James R Sowers
Journal:  Prog Cardiovasc Dis       Date:  2010 Mar-Apr       Impact factor: 8.194

Review 7.  Rationale for the use of aldosterone antagonists in congestive heart failure.

Authors:  Ricardo Rocha; Gordon H Williams
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways.

Authors:  Ross D Feldman; Robert Gros
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 9.  Mineralocorticoid receptor antagonists and hypertension: is there a rationale?

Authors:  Olga Gumieniak; Gordon H Williams
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 10.  Aldosterone receptor antagonists: biology and novel therapeutical applications.

Authors:  P Magni; M Motta
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.